Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MicroRNAs.

Muller Fabbri1, Carlo M Croce, George A Calin

  • 1Human Cancer Genetics, Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, OH, USA.

Cancer Journal (Sudbury, Mass.)
|February 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Oncotarget·2018
Same author

Loss of miR-204 expression is a key event in melanoma.

Molecular cancer·2018
Same author

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Molecular and cellular biology·2018
Same author

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Oncotarget·2018
Same author

Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.

Cancer letters·2018
Same author

The role of MicroRNAs in human cancer.

Signal transduction and targeted therapy·2017
Same journal

Present and Emerging Strategies for Disease Assessment in Hodgkin Lymphoma.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Management of Classic Hodgkin Lymphoma in Special Clinical Situations.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Older Patients With Hodgkin Lymphoma: A Contemporary Review.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma: A Review as a Case Study in AYA Cancer Care.

Cancer journal (Sudbury, Mass.)·2026
Same journal

Hodgkin Lymphoma: Management of Patients Who Fail Primary Therapy.

Cancer journal (Sudbury, Mass.)·2026
See all related articles

MicroRNAs (miRNAs) are small RNAs regulating genes, impacting human diseases like cancer. These molecules can function as oncogenes or tumor suppressors, with potential as cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are small, noncoding RNAs involved in gene regulation.
  • miRNAs play a critical role in the development and progression of various human diseases, notably cancer.
  • Their dual role as oncogenes or tumor suppressors highlights their complex involvement in tumorigenesis.

Purpose of the Study:

  • To review the multifaceted roles of microRNAs in human cancer.
  • To discuss the implications of miRNA mutations and polymorphisms in cancer predisposition.
  • To explore the diagnostic, prognostic, and therapeutic potential of miRNAs in oncology.

Main Methods:

  • Literature review of studies on microRNA function in cancer.
  • Analysis of research on genetic alterations (mutations, polymorphisms) affecting miRNAs.

Related Experiment Videos

  • Examination of data on miRNA expression profiling for diagnosis and prognosis.
  • Assessment of preclinical and clinical investigations into miRNA-based cancer therapies.

    • Main Results:

    • MicroRNAs exhibit complex regulatory functions, acting as oncogenes or tumor suppressors in cancer.
    • Germline and somatic mutations, as well as polymorphisms, contribute to an individual's susceptibility to cancer.
    • Altered miRNA expression levels are associated with cancer diagnosis and patient outcomes.
    • Emerging evidence supports the potential of miRNAs as novel anticancer therapeutic agents.

    Conclusions:

    • MicroRNAs are pivotal regulators in cancer, influencing disease development and progression.
    • Genetic variations in miRNAs can predispose individuals to cancer.
    • miRNAs hold significant promise for cancer diagnostics, prognostics, and targeted therapies.